247 related articles for article (PubMed ID: 28371665)
1. Mutation matters in precision medicine: A future to believe in.
Dey N; Williams C; Leyland-Jones B; De P
Cancer Treat Rev; 2017 Apr; 55():136-149. PubMed ID: 28371665
[TBL] [Abstract][Full Text] [Related]
2. Precision medicine for metastatic breast cancer--limitations and solutions.
Arnedos M; Vicier C; Loi S; Lefebvre C; Michiels S; Bonnefoi H; Andre F
Nat Rev Clin Oncol; 2015 Dec; 12(12):693-704. PubMed ID: 26196250
[TBL] [Abstract][Full Text] [Related]
3. Genomics-driven oncology: framework for an emerging paradigm.
Garraway LA
J Clin Oncol; 2013 May; 31(15):1806-14. PubMed ID: 23589557
[TBL] [Abstract][Full Text] [Related]
4. The genomic landscape of breast cancer and its interaction with host immunity.
Luen S; Virassamy B; Savas P; Salgado R; Loi S
Breast; 2016 Oct; 29():241-50. PubMed ID: 27481651
[TBL] [Abstract][Full Text] [Related]
5. Precision Medicine in Breast Cancer.
Odle TG
Radiol Technol; 2017 Mar; 88(4):401M-421M. PubMed ID: 28298516
[TBL] [Abstract][Full Text] [Related]
6. Successes and limitations of targeted cancer therapy in breast cancer.
Curigliano G; Criscitiello C
Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
[TBL] [Abstract][Full Text] [Related]
7. Precision medicine for metastatic breast cancer.
Deluche E; Onesti E; Andre F
Am Soc Clin Oncol Educ Book; 2015; ():e2-7. PubMed ID: 25993174
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral heterogeneity and subclonal diversification of early breast cancer.
Yates LR
Breast; 2017 Aug; 34 Suppl 1():S36-S42. PubMed ID: 28666921
[TBL] [Abstract][Full Text] [Related]
9. Genetics and Genomics of Breast Cancer: update and translational perspectives.
Biancolella M; Testa B; Baghernajad Salehi L; D'Apice MR; Novelli G
Semin Cancer Biol; 2021 Jul; 72():27-35. PubMed ID: 32259642
[TBL] [Abstract][Full Text] [Related]
10. Cancer classification in the genomic era: five contemporary problems.
Song Q; Merajver SD; Li JZ
Hum Genomics; 2015 Oct; 9():27. PubMed ID: 26481255
[TBL] [Abstract][Full Text] [Related]
11. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
12. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
15. Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer.
Bottosso M; Mosele F; Michiels S; Cournède PH; Dogan S; Labaki C; André F
ESMO Open; 2024 Mar; 9(3):102247. PubMed ID: 38401248
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing.
Liu S; Wang H; Zhang L; Tang C; Jones L; Ye H; Ban L; Wang A; Liu Z; Lou F; Zhang D; Sun H; Dong H; Zhang G; Dong Z; Guo B; Yan H; Yan C; Wang L; Su Z; Li Y; Huang XF; Chen SY; Zhou T
Hum Genomics; 2015 Feb; 9(1):2. PubMed ID: 25757876
[TBL] [Abstract][Full Text] [Related]
17. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
18. The value of genomic analysis of breast cancer in drug development.
Szekely B; Pusztai L
J Natl Cancer Inst Monogr; 2011; 2011(43):60-2. PubMed ID: 22043042
[TBL] [Abstract][Full Text] [Related]
19. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
Andre F; Vicier C; Delaloge S
Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
[TBL] [Abstract][Full Text] [Related]
20. Omics-based medicine and systems pathology. A new perspective for personalized and predictive medicine.
Tanaka H
Methods Inf Med; 2010; 49(2):173-85. PubMed ID: 20177649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]